Rheumatoid Arthritis Insights

Biological DMARDs May Influence Remission Odds in Patients

Research suggests that the likelihood of achieving DMARD-free remission in rheumatoid arthritis may be influenced by the use of biological DMARDs. Patients who have used biological DMARDs might have a different prognosis for sustained remission compared to those who have not.

Vagus Nerve Stimulation May Soon Treat Inflammatory Conditions

Vagus nerve stimulation, a potential new treatment for rheumatoid arthritis, is anticipated to receive approval, offering a promising alternative for managing the condition. This approach could help fill the demand for more effective and diverse treatment options for rheumatoid arthritis patients.

How RA Treatment Affects Fertility in Women Trying to Conceive

Women with rheumatoid arthritis face unique challenges when trying to conceive, as certain medications can affect fertility and pregnancy outcomes. A balanced treatment approach is crucial to manage RA symptoms while minimizing risks during conception and pregnancy.

Lung Ultrasound Can Identify Interstitial Lung Disease in Asymptomatic RA Patients

Researchers have found that lung ultrasound (LUS) can effectively identify interstitial lung disease in people with rheumatoid arthritis, even if they don't show symptoms. This method could help early detection and treatment of lung complications associated with rheumatoid arthritis.

Recent studies have shed light on various aspects of rheumatoid arthritis (RA) management and associated conditions. Li et al. (2025) explored the Wutou-Guizhi decoction (WTGZD), a traditional Chinese medicine, finding it may suppress inflammatory immune responses in RA by inhibiting the expression of various RA-related factors. This suggests potential for WTGZD in RA therapeutic intervention.

Meanwhile, Gumtorntip et al. (2025) focused on the prevalence of sarcopenia in RA patients, highlighting the importance of recognizing and addressing muscle degeneration in RA management for improved health-related quality of life.

Lastly, Cooper (2025) reported that long-term elevated inflammation in RA patients increases the risk for interstitial lung disease (ILD), emphasizing the need for consistent monitoring and management of inflammation in RA.